Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest VGX Animal Health Stories

2012-10-15 03:24:28

BLUE BELL, Pa., Oct. 15, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its majority-owned subsidiary, VGX Animal Health, has received approval to market LifeTide® SW 5.0, the world's first approved growth hormone releasing hormone (GHRH) therapy for food animals, in New Zealand. LifeTide is a once-in-a-lifetime treatment for female pigs (sows) that has demonstrated significant decreases in perinatal mortality of piglets from treated...

2012-09-16 22:20:57

THE WOODLANDS, Texas, Sept. 17, 2012 /PRNewswire/ -- VGX Animal Health, a majority-owned subsidiary of Inovio Pharmaceuticals (NYSE MKT: INO), announced today that a study published in a leading peer-reviewed journal showed that LifeTide® SW 1.0, an optimized version requiring only 20% of the dose of the licensed LifeTide® SW 5.0, demonstrated significant decreases in perinatal mortality rate, an increase in the number of pigs born alive, and an increase in the weight and number of...